Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Jun 15, 2023; 15(6): 1086-1095
Published online Jun 15, 2023. doi: 10.4251/wjgo.v15.i6.1086
Figure 1
Figure 1 Diagnostic value evaluation of the indicator for differentiation between the healthy control group and colorectal cancer group. A: CEA and CAMK1D used alone to differentiate between the 195 healthy controls and 101 colorectal cancer patients; B: CEA and CAMK1D joint model for the differentiation of the 195 healthy controls and 101 colorectal cancer patients; C: CEA and CAMK1D joint model for the differentiation of the 195 healthy controls and 38 early colorectal cancer patients; D: CEA and CAMK1D joint model for the differentiation of the 195 healthy controls and 63 advanced colorectal cancer patients.